Status:
UNKNOWN
A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Conditions:
Premature Ovarian Insufficiency
Eligibility:
FEMALE
18-39 years
Brief Summary
Premature ovarian insufficiency (POI) refers to the occurrence of ovarian hypofunction in women before the age of 40, which seriously affects women's overall health and quality of life. However, there...
Eligibility Criteria
Inclusion
- Age 18-39 years old
- Meet POI diagnostic criteria
- Volunteer to participate in this study and willing to cooperate with the investigation
Exclusion
- Reproductive endocrine disease
- Those receiving hormone supplementation and other steroid-containing drug therapy now or within half a year
- Chromosomal abnormalities
- Pregnancy and breastfeeding women
- Uncontrolled endocrine system diseases
- Uncontrolled cardiovascular system diseases
- Uncontrolled autoimmune related diseases
- Abnormal liver function
- Abnormal kidney function
- Abnormal coagulation function
- Severe anemia
- History of malignant tumors
- History of radiotherapy
- History of chemotherapy
- Mental impairment
- Cognitive impairment
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06067529
Start Date
November 1 2023
End Date
December 31 2025
Last Update
October 5 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, China, 310000
2
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, China, 310000